Results 191 to 200 of about 61,573 (234)

Cefepime/Tazobactam Compared With Other Tazobactam Combinations Against Problem Gram-Negative Bacteria [PDF]

open access: yesInternational Journal of Antimicrobial Agents, 2021
Objectives: Piperacillin/tazobactam has long been a broad-spectrum ‘workhorse’ antibiotic; however, it is compromised by resistance. One response is to re-partner tazobactam with cefepime, which is easier to protect, being less β-lactamase labile, and to
Shazad Mushtaq   +2 more
exaly   +2 more sources

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination With Cefepime in an in Vitro Infection Model. [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 2017
We previously demonstrated that for tazobactam administered in combination with ceftolozane, the pharmacokinetic-pharmacodynamic (PK-PD) index that best described tazobactam efficacy was the percentage of the dosing interval that tazobactam ...
Brian D Vanscoy   +2 more
exaly   +2 more sources

Structural studies on tazobactam

Journal of Medicinal Chemistry, 1991
Tazobactam (3, C10H12N4O5S) is an effective inhibitor of bacterial beta-lactamases. It crystallizes with unit cell dimensions a = 10.230 (2) A, b = 14.396 (2) A, and c = 17.291 (2) A in space group P2(1)2(1)2(1). Compared to the related inhibitor sulbactam (2), which lacks the triazole ring, crystalline tazobactam exhibits very similar beta-lactam ...
C A, Toomer   +5 more
openaire   +2 more sources

Ceftolozane-Tazobactam Activity Against Pseudomonas aeruginosa Clinical Isolates From U.S. Hospitals: Report From the PACTS Antimicrobial Surveillance Program, 2012 to 2015.

open access: yesAntimicrobial Agents and Chemotherapy, 2017
The activity of ceftolozane-tazobactam was compared to the activities of 7 antimicrobials against 3,851 Pseudomonas aeruginosa isolates collected from 32 U.S.
Dee Shortridge   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy